Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases

Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases

US Patent 9468662 · Granted Oct 18, 2016

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for cancer imaging and radiotherapy2025
Aptamer-based CAR T-cell switch2025
Compositions and methods for cancer imaging and radiotherapy2023
Viral vector constructs for expression of genetic adjuvants activating the CD40 2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Composition comprising at least one water-soluble pharmaceutically acceptable sa2021
Binding molecules with antitumoral activity2017
Use of the pat nanopeptide in the treatment of autoimmune diseases2016
Use of the pat nanopeptide in the treatment of autoimmune diseases2016
IL-17 binding compounds and medical uses thereof2016
Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases2015
Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases2015